Lv11
50 积分 2023-09-04 加入
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
2小时前
已关闭
Growth Differentiation Factor–15 and Risk of CKD Progression
6天前
已完结
Potent Covalent Irreversible Inhibitor of KRAS G12C IBI351 in Patients with Advanced Solid Tumors: First-In-Human Phase I Study
12天前
已完结
Efficacy of immunotherapy inKRAS-mutant non-small-cell lung cancer with comutations
28天前
已完结
A Phase II Study of Neoadjuvant Opnurasib KRAS G12C inhibitor in Patients with Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol
1个月前
已完结
On the receiving end—patient perception of the side-effects of cancer chemotherapy
1个月前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
1个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
1个月前
已完结
Potent Covalent Irreversible Inhibitor of KRAS G12C IBI351 in Patients with Advanced Solid Tumors: First-In-Human Phase I Study
1个月前
已完结
Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies
2个月前
已完结
皖公网安备34019202002308
